BeeWell

Trials & centers

Ask your doctor

Pick a condition
Breast cancerLung cancerColorectal cancerProstate cancerPancreatic cancerOvarian cancerLeukemiaLymphomaBrain tumorMelanomaLiver cancerMultiple myeloma

Recruiting trials

Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma

Phase 2 Recruiting

  • Baptist - MD Anderson Cancer Center, Jacksonville, Florida, United States
  • Cooper Hospital UNIV MED CTR., Camden, New Jersey, United States
  • M D Anderson Cancer Center, Houston, Texas, United States
Official record

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

Phase 3 Recruiting

  • Honor Health Research Institute, Scottsdale, Arizona, United States
  • UCLA Medical Center, Los Angeles, California, United States
  • Angeles Clinic, Los Angeles, California, United States
  • More sites
Official record

Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma

Phase 2 Recruiting

  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Official record

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Phase 1 & 2 Recruiting

  • HonorHealth Research Institute, Scottsdale, Arizona, United States
  • Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
  • Yale Cancer Center, New Haven, Connecticut, United States
  • More sites
Official record

Sitagliptin With Pembro in RCC and Melanoma

Phase 1 Recruiting

  • University of Iowa, Iowa City, Iowa, United States
Official record

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Phase 1 Recruiting

  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Official record

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Phase 1 & 2 Recruiting

  • HonorHealth Research Institute, Scottsdale, Arizona, United States
  • Massachusetts General Hospital, Boston, Massachusetts, United States
  • Sarah Cannon Research Institute, Nashville, Tennessee, United States
  • More sites
Official record

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Phase 1 Recruiting

  • University of Michigan Hospitals, Ann Arbor, Michigan, United States
  • Case Comprehensive Cancer Center, Cleveland, Ohio, United States
  • Oregon Health & Science University, Portland, Oregon, United States
  • More sites
Official record
ClinicalTrials.gov

NCI-designated centers

Comprehensive & clinical

Alabama

Arizona

California

Colorado

Connecticut

District of Columbia

  • Georgetown Lombardi Comprehensive Cancer Center

    Washington, District of Columbia

    NCI listingPlan a trip

Florida

Georgia

Hawai'i

Illinois

Indiana

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana

    NCI listingPlan a trip

Iowa

Kansas

Kentucky

Maryland

  • Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland

    NCI listingPlan a trip

  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

    Baltimore, Maryland

    NCI listingPlan a trip

Massachusetts

Michigan

Minnesota

Missouri

Nebraska

New Hampshire

New Jersey

New Mexico

  • University of New Mexico Cancer Research and Treatment Center

    Albuquerque, New Mexico

    NCI listingPlan a trip

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

South Carolina

Tennessee

Texas

Utah

Virginia

Washington

  • Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium

    Seattle, Washington

    NCI listingPlan a trip

Wisconsin

NCI-Designated Cancer Centers, June 10, 2026